
Photo of Jayant Vaidya taken from ucl.ac.uk
Sep 6, 2024, 10:50
Jayant Vaidya: UK patients prefer receiving TARGIT-IORT while they are asleep during surgery
Jayant Vaidya, Professor of Surgery and Oncology,
“UK patients with breast cancer perceive even 5-day post-op radiotherapy as being greatly disruptive. They prefer receiving TARGIT-IORT while they are asleep during surgery – it gives them the feeling of stamping out the cancer without conscious awareness.”
Source: Jayant Vaidya/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 17:41
Jun 7, 2025, 16:47
Jun 7, 2025, 16:40
Jun 7, 2025, 16:30
Jun 7, 2025, 16:07
Jun 7, 2025, 15:49